IP Library › Patent Application 19259904
Patent Application
App. No. 19/259,904

MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
19/259,904
Abstract

The present invention provides compounds, compositions thereof, and methods of using the same.

Claims (32)

1 - 31 . (canceled)

32 . A process for preparing a compound selected from:

comprising hydrogenating a compound selected from:

33 . The process of claim 32 for preparing the compound selected from:

the process comprising subjecting a compound selected from:

to chiral chromatography.

34 . The process of claim 33 , wherein the chiral chromatography is reverse phase chromatography using a chiral column.

35 . The process of claim 33 for preparing the compound selected from:

the process comprising adding a carbobenzyloxy (Cbz) group to a compound selected from:

36 . The process of claim 35 , wherein the adding of a Cbz group comprises benzyl N-succinimidyl carbonate (Cbz-OSu) and sodium bicarbonate in aqueous acetone.

37 . The process of claim 35 for preparing the compound selected from:

the process comprising hydrogenating a compound selected from:

38 . The process of claim 37 , wherein the hydrogenation comprises palladium on carbon and ammonium formate in methanol.

39 . The process of claim 37 for preparing the compound selected from:

the process comprising treating a compound selected from:

with an acid.

40 . The process of claim 39 , wherein the acid is hydrogen chloride in acetic acid.

41 . The process of claim 39 for preparing the compound selected from:

the process comprising treating a compound selected from:

with benzylamine, acetic acid, and trimethylsilyl cyanide in diethyl ether.

42 . The process of claim 41 for preparing the compound selected from:

the process comprising treating a compound selected from:

with lithium aluminum hydride in tetrahydrofuran.

43 . The process of claim 42 for preparing the compound selected from:

the process comprising treating a compound selected from:

with (1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate (HATU), triethylamine or diisopropylethylamine, and N,O-dimethylhydroxylamine hydrochloride in N,N-dimethylformamide.

44 . The process of claim 43 for preparing the compound selected from:

the process comprising treating a compound selected from:

with lithium hydroxide in aqueous dimethylsulfoxide.

45 . The process of claim 44 for preparing the compound selected from:

the process comprising treating a compound selected from:

with methylmagnesium iodide, ethylmagnesium bromide, n-propylmagnesium bromide isopropylmagnesium bromide, or n-butylmagnesium bromide, and copper iodide in dichloromethane, tetrahydrofuran, or dichloromethane and tetrahydrofuran.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 6, 2026
From: NAVITOR PHARMACEUTICALS, INC.
To: SUPERNUS PHARMACEUTICALS, INC.
Reel/Frame 075552/0122 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2025
From: FETALVERO, KRISTINA MICHELLE; NARAYAN, SRIDHAR; O'NEILL, DAVID JOHN; SAIAH, EDDINE; SENGUPTA, SHOMIT
To: NAVITOR PHARMACEUTICALS, INC.
Reel/Frame 071627/0353 →